EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Three-year post-recurrence survival outcome by leukopenia grade 2+ during systemic chemotherapy in recurrent cervical cancer

Pornpawee Wangsatidtongbai, Rakchai Buhachat, Ekasak Thiangphak

Obstetrics & Gynecology Science · 15.05.2026 · 69 (3) · 202-211

DOI: 10.5468/ogs.26032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Obstetrics & Gynecology Science, erschienen am 15.05.2026. Verfasst von Pornpawee Wangsatidtongbai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ObjectiveThis study aimed to evaluate the association between grade ≥2 chemotherapy-induced leukopenia (CIL) and 3-year post-recurrence survival (PRS) in patients with recurrent cervical cancer (CC) undergoing systemic chemotherapy.MethodsWe conducted a retrospective comparative cohort study of patients with recurrent CC who received ≥3 cycles of systemic chemotherapy at a tertiary referral center between January 2000 and June 2022. Complete serial blood counts were performed for each cycle. Patients were classified according to the development of grade ≥2 leukopenia (white blood cell count

Schlagwörter

Stichwörter der Autor:innen

Antineoplastic combined chemotherapy protocolsLeukopeniaRecurrenceSurvival rateUterine cervical neoplasms

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
  • Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand. brakchai@yahoo.com.

Zitieren

APA

Wangsatidtongbai, P., Buhachat, R., & Thiangphak, E. (2026). Three-year post-recurrence survival outcome by leukopenia grade 2+ during systemic chemotherapy in recurrent cervical cancer. Obstetrics & Gynecology Science, 69(3), 202-211. https://doi.org/10.5468/ogs.26032

Vancouver

Wangsatidtongbai P, Buhachat R, Thiangphak E. Three-year post-recurrence survival outcome by leukopenia grade 2+ during systemic chemotherapy in recurrent cervical cancer. Obstetrics & Gynecology Science. 2026;69(3):202-211. doi:10.5468/ogs.26032

BibTeX
@article{Wangsatidtongbai2026,
  author = {Wangsatidtongbai, Pornpawee and Buhachat, Rakchai and Thiangphak, Ekasak},
  title = {Three-year post-recurrence survival outcome by leukopenia grade 2+ during systemic chemotherapy in recurrent cervical cancer},
  journal = {Obstetrics & Gynecology Science},
  year = {2026},
  volume = {69},
  number = {3},
  pages = {202--211},
  doi = {10.5468/ogs.26032}
}
Kostenlos starten →